electroCore to Announce Second Quarter Ended June 30, 2020 Financial Results on Thursday, August 13
Domestic: | 877-407-4018 |
International: | 201-689-8471 |
Conference ID: | 13706874 |
Webcast: | http://public.viavid.com/index.php?id=140717 |
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Investors:
617-430-7578
hans@lifesciadvisors.com
or
Media Contact:
electroCore
973-290-0097
jackie.dorsky@electrocore.com